Status:
RECRUITING
Improving Patient Reported Outcome Measures in Catheter Ablation
Lead Sponsor:
Barts & The London NHS Trust
Collaborating Sponsors:
University College, London
Conditions:
Ventricular Tachycardia
ICD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will assess whether more frequent measurement of patient reported outcome measures (PROMs) - specifically health related quality of life (HRQL) - can improve the evaluation of the clinical ...
Detailed Description
Patients who have been implanted with an ICD are at risk of suffering from dangerous arrhythmias such as VT. Patients can experience clinical events including worsening of any underlying heart failur...
Eligibility Criteria
Inclusion
- Adults (\>18 years) With an Implantable Cardioverter Defibrillator (ICD) implanted \>3 months from time of recruitment and a previous episode of documented VT requiring therapy from the ICD.
- And impaired LV/RV function Willing and able to give written informed consent
Exclusion
- Patients who are planning to move away from study site within 12 months of enrolment who wished to use postal method to complete their HRQL Patients who are unable to give informed consent
Key Trial Info
Start Date :
June 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04499326
Start Date
June 13 2024
End Date
December 31 2025
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St Bartholomew's Hospital
London, United Kingdom